We may be a step closer to a highly effective mRNA vaccine against HIV, but tests so far reveal that the approach can cause ...

In a small trial across ten U.S. research sites, a novel HIV vaccine candidate has shown a result that has eluded scientists ...

HIV vaccine efforts have been slowed by the difficulty of getting neutralizing antibodies to target the correct locations of ...

Several vaccines for HIV have been tested in animal studies and an early safety trial in people, showing promising results in both.

Evidence is growing that some HIV-infected infants, if given antiretroviral drugs early in life, are able to suppress their ...

Mutatation causes immunity to all viruses and researchers now want to build a treatment from it.

The National Institutes of Health canceled 53 grants to Colorado institutions earlier this year, according to the volunteer ...

The investigational tuberculosis vaccine M72/AS01E-4 has an acceptable safety profile and robust immunogenicity among ...

Starting in the mid-2010s, the University of Oxford pediatrician and immunologist began working with scientists in the South African province of KwaZulu-Natal, with the aim of tracking several hundred ...

Regulatory agencies are offering more flexibility when it comes to viral clearance strategies, but this must be aligned with ...

The researchers had hoped to find that early ART had a greater impact on preventing chronic inflammation, but the results ...